产品类别

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

VEGF-A polyclonal antibody

货号: BS6496

价格：￥ 1140

货期：现货（1-2个工作日）

25ul 50ul 100ul 200ul

抗体定制服务咨询

说明书 MSDS SHIP

详细信息检测数据实验指南文献

No. :BS6496

Product Name :VEGF-A polyclonal antibody

Swiss-Prot :P15692

Host :Rabbit

Reactivity :Human,Mouse,Rat

Applications :WB IF/ICC IHC-P

Application_all :WB: 1:500-1:1000 IF/ICC: 1:50-1:200 IHC-P: 1:50-1:200

Background :VEGF is a dimeric glycoprotein with structural homology to PDGF. Several variants of VEGF have been described that arise by alternative mRNA splicing. It has been speculated that VEGF may function as a tumor angiogenesis factor in vivo because the expression pattern of VEGF is consistent with a role in embryonic angiogenesis. VEGF mRNA is formed in some primary tumors, VEGF is produced by tumor cell lines in vitro and VEGF mitogenic activity appears to be restricted to endothelial cells. A member of the PDGF receptor family, Flt, has been identified as a high-affinity receptor for VEGF.

Product :Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Purification&Purity :The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity :VEGFA polyclonal antibody detects endogenous levels of VEGFA protein.

BiowMW :~ 27 kDa (VEGF206); 45 kDa (L-VEGF206); ~ 15-44 kDa (Others Isoform)

Note :For research use only, not for use in diagnostic procedure.

Alternative Name :Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGFA; VEGF

Immunogen :Recombinant full length Human VEGF-A.

Conjugate :Unconjugated

Modification :Unmodification

Western blot (WB) analysis of VEGF-A polyclonal antibody

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway

JournalOncoTargets and Therapy

ApplicationWB

IF3.046

SpeciesHuman

PMID30104883